| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
David R Stevens last filed a Form 4 in May 2023, as Director at AMPE. David R Stevens's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 103,971 shares of AMPE. Net of sales, the AMPE filings show accumulation of 95,000 shares.
David R Stevens has 17 Form 4 filings on record from January 2015 to May 2023, all as Director at Ampio Pharmaceuticals (AMPE), 2015–2023.
The 23 reported transactions were 9 option or other derivative awards, 7 stock awards, 4 dispositions back to the company and 3 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $21K and no sales.
The only open-market purchase was 95,000 shares of AMPE at an average $0.22 on May 12, 2023, about $21K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 12, 2023 | AMPE Ampio Pharmaceuticals, Inc. | Director | Buy | 95,000 | $0.22 | $20,775.00 | +1,059% |